Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Total Non-Current Liabilities: 2009-2021

Historic Total Non-Current Liabilities for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to $165.1 million.

  • Avadel Pharmaceuticals' Total Non-Current Liabilities fell 5.38% to $152.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $152.5 million, marking a year-over-year decrease of 5.38%. This contributed to the annual value of $165.1 million for FY2021, which is 13.74% up from last year.
  • As of FY2021, Avadel Pharmaceuticals' Total Non-Current Liabilities stood at $165.1 million, which was up 13.74% from $145.2 million recorded in FY2020.
  • Avadel Pharmaceuticals' Total Non-Current Liabilities' 5-year high stood at $173.5 million during FY2018, with a 5-year trough of $145.2 million in FY2020.
  • In the last 3 years, Avadel Pharmaceuticals' Total Non-Current Liabilities had a median value of $165.1 million in 2021 and averaged $160.7 million.
  • Per our database at Business Quant, Avadel Pharmaceuticals' Total Non-Current Liabilities decreased by 18.94% in 2017 and then climbed by 13.74% in 2021.
  • Avadel Pharmaceuticals' Total Non-Current Liabilities (Yearly) stood at $160.6 million in 2017, then grew by 8.03% to $173.5 million in 2018, then declined by 1.01% to $171.8 million in 2019, then decreased by 15.49% to $145.2 million in 2020, then grew by 13.74% to $165.1 million in 2021.